The platform relies on curated, hand-selected, and quarterly updated clinical and policy databases, substantially ensuring highly accurate, guideline-aligned, and deeply personalized output. The resulting appeal letters have been rigorously developed and tested over the past twelve months and consistently exceed the quality and specificity typically achievable through manual drafting alone by physicians, clinical staff, or administrative staff.
We place a strong emphasis on quality and provide white-glove support during the initial months of implementation with client teams.
Operationally, this product has demonstrated an 80–90% reduction in appeals drafting and review burden, with an associated 30%+ improvement over your baseline approval success rate, a 10%+ increase in patient census per month, and a 5-10%+ increase in commercial payor mix above your baseline. All of this, alongside a commandingly high 9/10 physician satisfaction rating. Financially, we project a 7-8 figure return within 12-18 months and based on our experience, our product strategy and tools approach a 200%+ ROI.
This platform was designed to enhance existing teams — not replace them — thereby strengthening team culture, reducing burnout, and improving interdisciplinary harmony.
Currently available for proton workflows, with expansion to photon workflows within the next three months.